We invite you to explore the colorful world of digital PCR and join the upcoming Digital PCR Festival 2.0. JETA Molecular´s CEO, Doug Bost, will be addressing the benefits of this ultrasensitive detection method for post-transplant patient monitoring in his presentation called “Applications of Digital PCR for Monitoring Transplant Success – Stem Cell Chimerism Analysis” during the Translational Research session.

The 36th European Immunogenetics and Histocompatibility Conference was held in Nantes on April 26-29, 2023. The organizers did anamazing job to combine the scientific/educational part with a nice social program in beautiful scenes of the historical capital of Brittany.

JETA Molecular has recently developed six new assays for the increasingly popular panel of HLA TRACE™ Assays, designed to monitor the loss of HLA heterozygosity following haploidentical HSCT. All the new HLA assays target alleles from MHC Class B.

The HLA TRACE™ panel of assays, designed for the HLA loss of heterozygosity monitoring, is growing again with four new assays being available to our customers now. This brings the total number of HLA TRACE™ Assays to 32.

The new HoloGRAFT cfDNA dPCR monitoring kit, designed for the quantification of tiny amounts of cell-free DNA, serving as a biomarker of organ health in patients after solid organ transplantation, has been presented during the first-ever Innovation Forum virtual event. This webinar, organized by QIAGEN, focuses on the latest innovations in life sciences and offers exciting talks by expert scientists, among others on personalized cancer care, antibiotic resistance, mRNA vaccines or novel drug targets.